Ivory Coast toxic clean-up offer

| | Comments (1)

BBC NEWS:
February 13, 2007

Dutch-based oil trading group Trafigura is to pay the Ivorian government $198m (£102m) for a clean-up and inquiry after a"toxic waste" incident in 2006.

Trafigura say this is not "damages" and that there is no admission of liability on their part for whatever happened.

Ten people died and many fell ill after waste was shipped to Abidjan and left around the city in August.

As part of the deal, the Ivory Coast will drop any prosecutions or claims, now or in the future, against the firm.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
www.ahrp.org
ahrp.blogspot.com
February 9, 2007

There are 61.5 million dogs in the U.S.--So with help from psychiatry and the FDA guess who has been eyeing this "underutilized" market population?

Eli Lilly is repackaging its antidepressant, Prozac, as a veterinary drug under brand name, RECONCILE.

"I've seen shy dogs become sociable, fierce dogs become friendly, and neurotic dogs become normal," says Manhattan animal psychiatrist Bert Barkowitz. And his patients seem to agree.

And Pfizer received approval for a weight loss drug, SLENTROL, for dogs!!!!!!!!!!!!!

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Monsanto Dumped Toxic Waste in UK

| | Comments (0)

Common Dreams News Center
February 12, 2007
The Guardian/UK
by John Vidal

Inquiry after chemicals found at site 30 years after their disposal

Evidence has emerged that the Monsanto chemical company paid contractors to dump thousands of tonnes of highly toxic waste in British landfill sites, knowing that their chemicals were liable to contaminate wildlife and people. Yesterday the Environment Agency said it had launched an inquiry after the chemicals were found to be polluting underground water supplies and the atmosphere 30 years after they were dumped.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

CASPIAN
www.spychips.com
www.nocards.org
By Katherine Albrecht
For immediate release
February 12, 2007

Human Chipping Company Omits Salient Risks from IPO Disclosure

VeriChip Corporation, the much-hated purveyor of the VeriChip human ID implant, is airing its dirty laundry this week. This is not by choice, mind you, but because the Securities and Exchange Commission (SEC) required the company to disclose its "risk factors" prior to launching its initial public offering of stock (IPO) Friday.

The company lays out nearly 20 pages of risk factors in its Form S-1 Registration Statement, a required document for the IPO. But what the company failed to reveal in its filing may be even more eye-opening, say CASPIAN privacy advocates Dr. Katherine Albrecht and Liz McIntyre. The pair, authors of the "Spychips" series of books, have been vocal critics of VeriChip, dogging the company in recent years and facing down its senior executives on radio and national television.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
http://www.ahrp.org
http://ahrp.blogspot.com

"According to a notice published Friday by the US Food and Drug Administration (FDA), from October 2005 through September 2006, companies had yet to initiate 71 percent of outstanding "post-market" safety evaluations that companies have promised to undertake for currently approved products they are already selling to consumers."

"The FDA reported that of the 1,259 "open post-marketing commitments" tied to already-approved drugs, 899 were still "pending," meaning the studies had not yet begun. Only 15 percent of the studies were currently underway. Another 3 percent were officially behind schedule. Within the year, only 160 post-marketing commitments were fully concluded with all study requirements met. "

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Press Release
Crusador
Source: www.putchildrenfirst.org
February 12, 2007

Crusador Comment: On Friday the Associated Press ran a story that said 1 in 150 children now have autism. Until the medical community takes a look at the role of mercury toxicity in this epidemic they will never get to the bottom of the problem. Isn't it interesting that pregnant women are told to avoid alcohol and smoking during pregnancy to protect the child yet almost every single OBGYN clinic in the U.S. has signs hanging up all around their offices that strongly recommend pregnant women take a flu shot? How is it that people can't make the association between these issues. Are we supposed to somehow believe that the mercury in the flu shots won't harm the child in the womb? It's ridiculous. Below is an intersting story we came across that all pregnant women need to read.

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (1 votes cast)

By Byron J. Richards, CCN
February 9, 2007
NewsWithViews.com

The FDA is steamrolling its way to a grand vision of repressive health care based on profits for Big Pharma and new biotech companies at the expense of human health.

Human death means little to the FDA, permitting mass killings of Americans while protecting Big Pharma profits. This year the FDA is being given more money (federal funding up 5% to 1.5 billion) without any accountability or effective Congressional oversight. This means that instead of using the money to meaningfully improve drug safety, the FDA will carry on its pet projects that include forwarding the health component of the Bush administration’s North American Union, limiting health freedom by harassing dietary supplement companies so as to reduce access to safe and effective drug competition, and actively turning the FDA into a drug company.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

By Byron J. Richards, CCN
February 9, 2007
NewsWithViews.com

Health Care for Profit

Wall Street, international bankers, President Bush, pharmaceutical companies, new biotech companies, the Rockefeller empire, and the FDA have created a new plan for public health. It is a grand vision based on profit. It will use the FDA and, as needed, the Department of Homeland Security as the regulatory police force that ensures compliance in the name of public safety. Legitimate objections may be overpowered in the name of national security.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

EU relaxes 15-year usage norm for Indian herbal exports
23/01/2007

(see original here)

The European Union has relaxed its norms of 15-year usage criteria under the Herbal Medicinal Product Directive that posed technical barriers to the Indian exporters of herbal products.

With this relaxation of its rules, any manufacturing unit can file a dossier of their products having less than 15 years of documented usage in any of the European Union countries and such a product can be considered for market authorization, Department of Ayush clarified.

Dr Konstantin Keller, chairman of the committee on Herbal Medicinal Products (HMPC), European Medicines Agency (EMEA) and Department for International Pharmaceutical Affairs, Federal Ministry of Health, Germany, made this point clear in his talks with AYUSH secretary Anita Das. He is, currently, leading an expert delegation of the European Commission on pharma and biotechnology.

Both the sides held detailed discussions on various issues relating to regulation of teaching practice and quality control of Ayurvedic products in the country. The Indian side expressed its concerns arising out of the Herbal Medicinal Product Directive of the European Union.

The Indian side while appreciating European Union's public health concerns on safety and quality control of herbal medicinal products impressed upon the European Union expert team that the condition of 15 year usage in Europe and quantitative determination of all the ingredients in any herbal formulation pose technical barriers to the trade of Ayurveda products in European Union.

The European team would be presenting their report to the India-EU Joint Working Group on Pharma and Biotechnology, which is scheduled to meet in New Delhi in the first quarter of 2007 for further steps.

European Commission also invited Indian scientists and experts in Ayurvedic drugs to participate in the process of development of monographs on medicinal plants being prepared by EMEA.

Other members of the delegation are Rul Santos Ivo, Policy Officer-Administrator, Pharmaceuticals Unit, European Commission and Anthony Humphreys, head of the regulatory affairs and organisational support sector, EMEA.

The Indian side emphasized that Ayurveda is a holistic health science and its teaching, practice and products are properly regulated in India and EU's concerns relating to safety and quality control are being addressed by mandatory testing for heavy metals/microbial load/pesticide residue and institution of export inspection mechanism.

Earlier the members of the commission visited Maharishi Ayurved manufacturing unit in Noida, regional research laboratory, CSIR, Jammu and Arya Vaidyasala, Kottakal to get first hand experience of standardization and quality control work being done on Ayurveda products and authentic Ayurvedic treatment for chronic disease conditions.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

NewsTarget Insider
February 8, 2007
By Mike Adams

(NewsTarget / Opinion) This is an important health freedom update from Mike Adams. If you believe in your health freedom, and you believe that forced vaccinations of children have gone too far, then you need to know the real story about what's happening in Texas right now.

Texas-Vaccine-House 150-2

Here's a thumbnail of the CounterThink cartoon we posted on this issue today. Click the thumbnail on the left to see the full cartoon.

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (2 votes cast)

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Recent Comments

Other sites of ours